These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8658708)

  • 21. Oral administration of FK 506 in a swine model of liver-small bowel allotransplantation.
    Reggiani P; Gatti S; Rossi G; Orsenigo R; Maggi U; Leoni L; Ceccherelli F; Colledan M; Gridelli B; Piazzini-Albani A; Galmarini M; Andreani P; Bardella MT; Langer M; Doglia M; Fassati LR; Galmarini D
    Transplant Proc; 1996 Oct; 28(5):2587-8. PubMed ID: 8907965
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetic interaction between tacrolimus and berberine in a child with idiopathic nephrotic syndrome.
    Hou Q; Han W; Fu X
    Eur J Clin Pharmacol; 2013 Oct; 69(10):1861-2. PubMed ID: 23765408
    [No Abstract]   [Full Text] [Related]  

  • 23. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
    Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of the jejunum and ileum in the first-pass effect as absorptive barriers for orally administered tacrolimus.
    Shimomura M; Masuda S; Saito H; Sakamoto S; Uemoto S; Tanaka K; Inui K
    J Surg Res; 2002 Apr; 103(2):215-22. PubMed ID: 11922737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients.
    Pea F; Tavio M; Pavan F; Londero A; Bresadola V; Adani GL; Furlanut M; Viale P
    Antivir Ther; 2008; 13(5):739-42. PubMed ID: 18771060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endotracheal calcineurin inhibition ameliorates injury in an experimental model of lung ischemia-reperfusion.
    Woolley SM; Farivar AS; Naidu BV; Rosengart M; Thomas R; Fraga C; Mulligan MS
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):376-84. PubMed ID: 14762344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of P-glycoprotein in the hepatic metabolism of tacrolimus.
    Jeong H; Chiou WL
    Xenobiotica; 2006 Jan; 36(1):1-13. PubMed ID: 16507509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physicochemical, pharmacokinetic and pharmacodynamic evaluation of liposomal tacrolimus (FK 506) in rats.
    Lee MJ; Straubinger RM; Jusko WJ
    Pharm Res; 1995 Jul; 12(7):1055-9. PubMed ID: 7494802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of topical tacrolimus and pimecrolimus to treat psoriasis: a review.
    Scheinfeld N
    Dermatol Online J; 2004 Jul; 10(1):3. PubMed ID: 15347485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome.
    Allen A; Siegfried E; Silverman R; Williams ML; Elias PM; Szabo SK; Korman NJ
    Arch Dermatol; 2001 Jun; 137(6):747-50. PubMed ID: 11405764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liposomal tacrolimus administered systemically and within the donor cell suspension improves xenograft survival in hemiparkinsonian rats.
    Alemdar AY; Baker KA; Sadi D; McAlister VC; Mendez I
    Exp Neurol; 2001 Dec; 172(2):416-24. PubMed ID: 11716565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects.
    Möller A; Iwasaki K; Kawamura A; Teramura Y; Shiraga T; Hata T; Schäfer A; Undre NA
    Drug Metab Dispos; 1999 Jun; 27(6):633-6. PubMed ID: 10348790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients.
    Jacobson P; Ng J; Ratanatharathorn V; Uberti J; Brundage RC
    Bone Marrow Transplant; 2001 Oct; 28(8):753-8. PubMed ID: 11781626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic absorption of topical tacrolimus in Pyoderma gangrenosum.
    Pitarch G; Torrijos A; Mahiques L; Sánchez-Carazo JL; Fortea JM
    Acta Derm Venereol; 2006; 86(1):64-5. PubMed ID: 16585995
    [No Abstract]   [Full Text] [Related]  

  • 35. Significance of newly developed liposomal FK 506 in canine liver transplantation.
    Ko S; Nakajima Y; Kanehiro H; Horikawa M; Yoshimura A; Taki J; Kido K; Aomatsu Y; Ueno M; Kin T
    Transplant Proc; 1995 Feb; 27(1):351-3. PubMed ID: 7533406
    [No Abstract]   [Full Text] [Related]  

  • 36. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
    Staatz CE; Willis C; Taylor PJ; Tett SE
    Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic study of FK 506 in the rat.
    Iwasaki K; Shiraga T; Nagase K; Hirano K; Nozaki K; Noda K
    Transplant Proc; 1991 Dec; 23(6):2757-9. PubMed ID: 1721268
    [No Abstract]   [Full Text] [Related]  

  • 38. [A monograph on topical tacrolimus (Protopic].
    Lübbe J; Saurat JH
    Ann Dermatol Venereol; 2003 Feb; 130(2 Pt 2):290-302. PubMed ID: 12700537
    [No Abstract]   [Full Text] [Related]  

  • 39. Bioequivalence of a new strength tacrolimus capsule under development.
    Bekersky I; Dressler D; Boswell GW; Fergen B; Tracewell W; Mekki Q
    Transplant Proc; 1998 Jun; 30(4):1457-9. PubMed ID: 9636591
    [No Abstract]   [Full Text] [Related]  

  • 40. A pilot study on sublingual administration of tacrolimus.
    van de Plas A; Dackus J; Christiaans MH; Stolk LM; van Hooff JP; Neef C
    Transpl Int; 2009 Mar; 22(3):358-9. PubMed ID: 18980626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.